Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsAESAES Initiated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.16+0.9% $11.00UnderperformAPGEApogee Therapeutics Initiated byCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$43.85+0.9% $89.00BuyAPGEApogee Therapeutics Initiated byCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$43.85+0.9% $89.00BuyARMARM Initiated byUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$139.68+2.7% $160.00BuyCNTXContext Therapeutics Initiated byD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.46+5.0% $9.00BuyCOURCoursera Initiated byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$7.90+11.1% $8.00Neutral140% Yields From Stocks Like Tesla? Here's How (Black Friday Special) (Ad)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.Click now to learn how to have the chance at 140% yields before time runs out!CSWICSW Industrials Initiated byWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating$432.01+1.3% $425.00Equal WeightDRUGBright Minds Biosciences Initiated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating$38.59+9.2% $75.00OutperformFLGCFlora Growth Initiated byAegisSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.51+5.6% $4.00BuyHASIHannon Armstrong Sustainable Infrastructure Capital Initiated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$30.43+4.9% $40.00BuyIMUXImmunic Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.18+7.3% $10.00BuyMANHManhattan Associates Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$290.74+3.7% $326.00OverweightMARAMARA Initiated byBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating$26.42+1.5% $27.00Equal WeightNDAQNasdaq Initiated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$81.52+0.6%OutperformRMBSRambus Initiated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating$56.89+1.7% $90.00OutperformSHLSShoals Technologies Group Initiated byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.07+5.0% $6.00BuySPSCSPS Commerce Initiated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$193.39+2.3% $198.00NeutralSPXCSPX Technologies Initiated byWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$181.56+3.2% $199.00OutperformSRPTSarepta Therapeutics Initiated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$114.65+0.4% $80.00SellSTZConstellation Brands Initiated byBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating$241.67+0.8% $261.00NeutralTAPMolson Coors Beverage Initiated byBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating$60.67+0.5% $64.00NeutralVRDNViridian Therapeutics Initiated byTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.03+4.1%BuyVVXV2X Initiated byBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$60.58-0.2% $80.00BuyAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:32 AM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
